Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy

NCT05965388 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

5000

Enrollment

OTHER

Sponsor class

Conditions

HBV
HCC

Interventions

DRUG: nucleoside analogues or interferon

Sponsor

Wen-hong Zhang

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]